Wang Pei,Feng Jiexiong.The antibiotics treatment of cholangitis Post-Kasai Portoenterostomy: A multi-center study protocol[J].Journal of Clinical Pediatric Surgery,2019,18(11):922-926.[doi:10.3969/j.issn.1671—6353.2019.11.006]
胆道闭锁术后胆管炎抗生素分级治疗的多中心研究方案
- Title:
- The antibiotics treatment of cholangitis Post-Kasai Portoenterostomy: A multi-center study protocol
- Keywords:
- Biliary Atresia/DT; Cholangitis; Antibiotic Prophylaxis; Multicenter Studies; Research Design
- 分类号:
- R657.4+4;R575.7
- 摘要:
- 胆管炎是BA术后最常见的并发症，发生率为60%~90%，反复发作胆管炎是影响BA患儿术后生活质量的重要危险因素。目前胆管炎的治疗多为经验性用药，尚无统一治疗指南。本研究拟通过多中心、前瞻性随机对照试验研究对不同程度胆管炎进行抗生素分级治疗。研究拟招募190名胆道闭锁术后胆管炎患儿，根据胆管炎严重程度随机分为对照组（n=95）和试验组（n=95），对照组统一接受抗生素治疗，试验组根据胆管炎严重程度接受分级抗生素治疗，治疗3 d、7 d后评估各组胆管炎患儿的治疗效果。这一多中心前瞻性研究将为BA术后胆管炎患儿抗生素规范化治疗提供循证医学层面的证据。
- Abstract:
- Cholangitis is the most common postoperative complication of BA,and the incidence is about 60%~90%.Recurring cholangitis is an important risk factor affecting the postoperative life quality of children with BA.However,there is no unified guideline for the severity of cholangitis and the related treatment.Therefore,this study is a multi-center and prospective research,intending to clarify the antibiotics treatment of cholangitis.A total of 190 cholangitis children will be recruited and randomized into control group(n=95) and experimental group(n=95),all control groups were treated with the same antibiotics,and the experimental group were treated with different antibiotics according to the severity of cholangitis,then evaluate the cure rate 3 days and 7 days later.This multi-center prospective study may provide a reliable reference for the standardized treatment of cholangitis.
参考文献/References:
1 Hartley JL,Davenport M,Kelly DA.Biliary atresia[J].Lancet,2009,374(9702):1704-1713.DOI:10.1016/S0140-6736(09)60946-6.
2 Lang T,Kappler M,Dietz H,et al.Biliary atresia:which factors predict the success of a kasai operation? An analysis of 36 patients[J].Eur J Med Res,2000,5(3):110-114.
3 Chardot C,Carton M,Spire-Bendelac N,et al.Prognosis of biliary atresia in the era of liver transplantation:French national study from [1986] to 1996[J].Hepatology,1999,30(3):606-611.DOI:10.1002/hep.510300330.
4 Livesey E,Cortina Borja M,Sharif K,et al.Epidemiology of biliary atresia in England and Wales (1999-2006)[J].Arch Dis Child Fetal Neonatal Ed,2009,94(6):F451-F455.DOI:10.1136/adc.2009.159780.
5 Leonhardt J,Kuebler JF,Leute PJ,et al.Biliary atresia:lessons learned from the voluntary German Registry[J].Eur J Pediatr Surg,2011,21(2):82-87.DOI:10.1055/s-0030-1268476.
6 Chardot C,Carton M,Spire-Bendelac N,et al.Is the kasai operation still indicated in children older than 3 months diagnosed with biliary atresia?[J].J Pediatr,2001,138(2):224-228.DOI:10.1067/mpd.2001.111276.
7 Superina R,Magee JC,Brandt ML,et al.The anatomic pattern of biliary atresia identified at time of kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival[J].Ann Surg,2011,254(4):577-585.DOI:10.1097/SLA.0b013e3182300950.
8 Wu ET,Chen HL,Ni YH,et al.Bacterial cholangitis in patients with biliary atresia[J].Pediatr Surg Int,2001,17(5-6):390-395.DOI:10.1007/s003830000573.
9 张璟,林涛,黄柳明,等.胆道闭锁术后反复发作性胆管炎抗感染治疗的中长期随访[J].临床小儿外科杂志,2016,15(1):20-22.DOI:10.3969/j.issn.1671-6353.2016.01.006. Zhang J,Lin T,Huang LM,et al.Outcomes of medium to long term follow-ups after anti-infective therapy for recurrent cholangitis after Kasai operation[J].J Clin Ped Sur,2016,15(1):20-22.DOI:10.3969/j.issn.1671-6353.2016.01.006.
10 Luo Q,Hao F,Zhang M,et al.Serum bacterial DNA detection in patients with cholangitis after Kasai procedure[J].Pediatr Int,2015,57(5):954-960.DOI:10.1111/ped.12737.
11 Luo Y,Zheng S.Current concept about postoperative cholangitis in biliary atresia[J].World J Pediatr,2008,4(1):14-19.DOI:10.1007/s12519-008-0003-0.
12 Bu LN,Chen HL,Chang CJ,et al.Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy[J].J Pediatr Surg,2003,38(4):590-593.DOI:10.1053/jpsu.2003.50128.
13 Wong KK,Fan AH,Lan LC,et al.Effective antibiotic regime for postoperative acute cholangitis in biliary atresia-an evolving scene[J].J Pediatr Surg,2004,39(12):1800-1802.DOI:10.1016/j.jpedsurg.2004.08.027.
14 Decharun K,Leys CM,West KW,et al.Prophylactic Antibiotics for Prevention of Cholangitis in Patients With Biliary Atresia Status Post-Kasai Portoenterostomy:A Systematic Review[J].Clin Pediatr (Phila),2016,55(1):66-72.DOI:10.1177/0009922815594760.
15 丁洁.关于多中心临床研究的思考[J].中华儿科杂志,2011,49(11):801-803.DOI:10.3760/cma.j.issn.0578-1310.2011.11.001. Ding J.Thoughts on multi-center clinical trials[J].Chinese Journal of Pediatrics,2011,49(11):801~803.DOI:10.3760/cma.j.issn.0578-1310.2011.11.001.
相似文献/References:
[1]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝组织MMP-1、MMP-2、TIMP-1的表达与预后研究[J].临床小儿外科杂志,2007,6(01):5.
[2]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝脏组织MMP-2、TGF-β_1的表达及意义[J].临床小儿外科杂志,2007,6(03):5.
[3]董淳强 杨体泉 董昆. 胆道闭锁术后早期胆管炎风险因素分析[J].临床小儿外科杂志,2013,12(05):348.
[4]陈功 郑珊 孙松. 不同年龄胆道闭锁患儿手术效果分析[J].临床小儿外科杂志,2014,13(01):22.
[5]谭梅军 陶强 黄金狮. IL-17在胆道闭锁患儿肝组织中的表达及意义[J].临床小儿外科杂志,2014,13(04):302.
[6]杨文萍 吴艳 张守华. 胆道闭锁患者肝脏组织病理改变的综合评价[J].临床小儿外科杂志,2015,14(01):10.
[7]李康 阳历 汤绍涛. 胆道闭锁患者肝内胆管γδT 细胞和调节性T细胞浸润及意义[J].临床小儿外科杂志,2015,14(01):16.
[8]刘丹丹 詹江华 高伟. 胆道闭锁患者肝门的病理解剖学研究[J].临床小儿外科杂志,2015,14(01):20.
[9]张震 李龙 乔国梁. 胆道闭锁Kasai术后生存率及条件生存率分析[J].临床小儿外科杂志,2015,14(01):25.
[10]庞文博 张廷冲 彭春辉. 强力抗感染和免疫调节预防Kasai术后近期胆管炎[J].临床小儿外科杂志,2015,14(01):29.
[11]余梦楠 刘钢 黄柳明 王伟. 胆道闭锁术后反复发作性胆管炎的细菌谱分析及抗生素选择[J].临床小儿外科杂志,2012,11(03):187.
[J].Journal of Clinical Pediatric Surgery,2012,11(11):187.
[12]詹江华,王智茹.聚焦胆道闭锁诊疗相关热点问题[J].临床小儿外科杂志,2023,22(03):201.[doi:10.3760/cma.j.cn101785-202212026-001]
Zhan Jianghua,Wang Zhiru.Focusing upon hot issues of diagnosing and treating biliary atresia[J].Journal of Clinical Pediatric Surgery,2023,22(11):201.[doi:10.3760/cma.j.cn101785-202212026-001]
[13]詹江华,孙溶涓,王智茹,等.日本《胆道闭锁临床实践指南》解读[J].临床小儿外科杂志,2023,22(03):205.[doi:10.3760/cma.j.cn101785-202212025-002]
Zhan Jianghua,Sun Rongjuan,Wang Zhiru,et al.Interpretations of Clinical Practice Guidelines for Biliary Atresia in Japan[J].Journal of Clinical Pediatric Surgery,2023,22(11):205.[doi:10.3760/cma.j.cn101785-202212025-002]
[14]赵一霖,吴晓霞,徐晓丹,等.巨细胞病毒感染对胆道闭锁Kasai手术预后影响的研究[J].临床小儿外科杂志,2023,22(03):232.[doi:10.3760/cma.j.cn101785-202212017-006]
Zhao Yilin,Wu Xiaoxia,Xu Xiaodan,et al.Prognosis of biliary atresia associated with cytomegalovirus[J].Journal of Clinical Pediatric Surgery,2023,22(11):232.[doi:10.3760/cma.j.cn101785-202212017-006]
[15]吴晓霞,刘文跃,孙雪,等.胆道闭锁患儿Kasai手术后频发胆管炎的危险因素及预后分析[J].临床小儿外科杂志,2023,22(03):244.[doi:10.3760/cma.j.cn101785-202212005-008]
Wu Xiaoxia,Liu Wenyue,Sun Xue,et al.Risk factors and prognosis of recurrent cholangitis after Kasai in biliary atresia patients[J].Journal of Clinical Pediatric Surgery,2023,22(11):244.[doi:10.3760/cma.j.cn101785-202212005-008]
[16]王磊,兰照平,高琪,等.胆道闭锁患儿Kasai手术后胆管炎的危险因素分析[J].临床小儿外科杂志,2023,22(11):1039.[doi:10.3760/cma.j.cn101785-202211061-007]
Wang Lei,Lan Zhaoping,Gao Qi,et al.Analysis of risk factors for cholangitis after Kasai procedure in biliary atresia children[J].Journal of Clinical Pediatric Surgery,2023,22(11):1039.[doi:10.3760/cma.j.cn101785-202211061-007]
[17]胡书奇,韩一江,赵晓霞,等.Ⅲ型胆道闭锁患儿术前基质金属蛋白酶水平与Kasai手术后预后的相关性研究[J].临床小儿外科杂志,2024,(08):723.[doi:10.3760/cma.j.cn101785-202405079-005]
Hu Shuqi,Han Yijiang,Zhao Xiaoxia,et al.Prognostic value of preoperative serum levels of MMPs in children of biliary atresia[J].Journal of Clinical Pediatric Surgery,2024,(11):723.[doi:10.3760/cma.j.cn101785-202405079-005]
[18]陈迪,郑珊,陈功.胆道闭锁Kasai肝门空肠吻合术后使用抗生素预防胆管炎的系统综述[J].临床小儿外科杂志,2024,(08):737.[doi:10.3760/cma.j.cn101785-202405049-007]
Chen Di,Zheng Shan,Chen Gong.Antibiotic use for preventing cholangitis after Kasai portoenterostomy in biliary atresia patients:a systematic review[J].Journal of Clinical Pediatric Surgery,2024,(11):737.[doi:10.3760/cma.j.cn101785-202405049-007]
备注/Memo
收稿日期:2017-04-18。
基金项目:国家自然科学基金（编号：81873541）
通讯作者:冯杰雄,Email:fengjiexiong@126.com